Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/33560
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ovchinnikov, D A | - |
dc.contributor.author | Jong, S | - |
dc.contributor.author | Cuddy, C | - |
dc.contributor.author | Scheffer, Ingrid E | - |
dc.contributor.author | Maljevic, S | - |
dc.contributor.author | Petrou, S | - |
dc.date | 2023 | - |
dc.date.accessioned | 2023-08-23T07:20:01Z | - |
dc.date.available | 2023-08-23T07:20:01Z | - |
dc.date.issued | 2023-08-08 | - |
dc.identifier.citation | Stem Cell Research 2023-08-08; 71 | en_US |
dc.identifier.issn | 1876-7753 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/33560 | - |
dc.description.abstract | A range of epilepsies, including the most severe group of developmental and epileptic encephalopathies (DEEs), are caused by gain-of-function variants in voltage-gated channels. Here we report the generation and characterisation of an iPSC cell line from the fibroblasts of a girl with early infantile DEE carrying heterozygous missense gain-of-function mutation (R1882Q) in Nav1.2(SCN2A) protein, using transient transfection with a single mRNA molecule. The established iPSC line displays typical human primed pluripotent stem cell characteristics: typical colony morphology and robust expression of pluripotency-associated marker genes, ability to give rise to derivatives of all three embryonic germ layers, and normal karyotype without any SNP array-detectable copy number variations. We anticipate that this iPSC line will be useful for the development of neuronal hyperactivity-caused human stem cell-based DEE models, advancing both understanding and potential therapy development for this debilitating condition. | en_US |
dc.language.iso | eng | - |
dc.title | Generation of an iPSC line (FINi001-A) from a girl with developmental and epileptic encephalopathy due to a heterozygous gain-of-function p.R1882Q variant in the voltage-gated sodium channel Nav1.2 protein encoded by the SCN2A gene. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Stem Cell Research | en_US |
dc.identifier.affiliation | The Florey Institute of Neuroscience and Mental Health | en_US |
dc.identifier.affiliation | Paediatrics | en_US |
dc.identifier.affiliation | Medicine (University of Melbourne) | en_US |
dc.identifier.affiliation | Royal Children's Hospital, Murdoch Children's Research Institute, Melbourne, VIC, Australia | en_US |
dc.identifier.affiliation | Praxis Precision Medicines, Cambridge, MA, USA | en_US |
dc.identifier.doi | 10.1016/j.scr.2023.103179 | en_US |
dc.type.content | Text | en_US |
dc.identifier.pubmedid | 37597357 | - |
dc.description.volume | 71 | - |
dc.description.startpage | 103179 | - |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Epilepsy Research Centre | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.